TD Asset Management »

Cytokinetics shares owned by TD Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 182k 83.49
2023-09-30 $2.9M 100k 29.46
2023-06-30 $2.4M 73k 32.62
2023-03-31 $2.6M 74k 35.19
2022-12-31 $2.3M 51k 45.82
2022-09-30 $1.9M 39k 48.93
2022-06-30 $1.2M 30k 39.27
2022-03-31 $1.1M 31k 36.82
2021-12-31 $383k 8.4k 45.60
2020-09-30 $773k 36k 21.65
2017-12-31 $149k 18k 8.14
2017-09-30 $265k 18k 14.48
2013-09-30 $143k 19k 7.58